The COVID-19 Pandemic and Dimensions of Substance Use: A Narrative Review and Living Repository of Primary Data


4. Association between substance use and SARS-CoV-2 infection risk, and clinical outcomes of COVID-19
  • Prevailing evidence are strongly indicative of worse SARS-CoV-2 infection risk and mortality outcomes among those with substance use compared to the general population

  • Ensuring access to healthcare among people with SUD during public health crises is a priority given increased vulnerability through multiple co-morbidities”

Repository


 
Navigate to each dimension
 
  1. Changes in propensity to use substances
  2. Changes in substance use contexts and behaviors
  3. Changes in drug markets
  4. Association between substance use and the SARS-CoV-2 infection risk and COVID-19 severity
  5. Changes in healthcare and harm reduction service access among PWUD.